Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2019-02-08

Clinical Trial Update: dorsaVi Back Pain and Movement Registry

View source ↗

Summary

The dorsaVi Back Pain and Movement Registry (NCT03001037) sponsored by dorsaVi Ltd is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: dorsaVi Ltd | Conditions: Low Back Pain | Status: SUSPENDED